» Authors » Chang-Chieh Hsu

Chang-Chieh Hsu

Explore the profile of Chang-Chieh Hsu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 62
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hsu C, Su Y, Rittenhouse-Olson K, Attwood K, Mojica W, Reid M, et al.
Cancer Res Commun . 2024 Jul; 4(8):1933-1945. PMID: 39015090
Significance: Exosomes or small extracellular vesicles have emerged as potent biomarkers of cancer liquid biopsy. We discovered a new exosomal carbohydrate marker, TF-Ag-α (Galβ1-3GalNAc-α), and showed that exosomal TF-Ag-α detected...
2.
Hsu C, Yang Y, Kannisto E, Zeng X, Yu G, Patnaik S, et al.
ACS Nano . 2023 May; 17(9):8108-8122. PMID: 37129374
Tumor derived exosomes (TEXs) have emerged as promising biomarkers for cancer liquid biopsy. Conventional methods (such as ELISA and qRT-PCR) and emerging biosensing technologies mainly detect a single type of...
3.
Hsu C, Wu Y
Exp Biol Med (Maywood) . 2022 Aug; 247(23):2152-2172. PMID: 35938477
Cancer liquid biopsy detects circulating biomarkers in body fluids, provides information that complements medical imaging and tissue biopsy, allows sequential monitoring of cancer development, and, therefore, has shown great promise...
4.
Hait N, Maiti A, Wu R, Andersen V, Hsu C, Wu Y, et al.
Cancer Gene Ther . 2022 Jun; 29(11):1662-1675. PMID: 35676533
The sialyltransferase ST6GAL1 that adds α2-6 linked sialic acids to N-glycans of cell surface and secreted glycoproteins is prominently associated with many human cancers. Tumor-native ST6GAL1 promotes tumor cell behaviors...
5.
Hsu C, Lin S, Chang C
ACS Appl Mater Interfaces . 2018 Feb; 10(9):7859-7870. PMID: 29405703
Photodynamic therapy (PDT) could be highly selective and noninvasive, with low side effects as an adjuvant therapy for cancer treatment. Because excitation sources such as UV and visible lights for...
6.
Tseng H, Pan L, Chen H, Liu W, Hsu C, Chen C
Biomed Mater Eng . 2015 Sep; 26 Suppl 1:S1677-83. PMID: 26405934
This study is the first to use 10- to 90-kg tissue-equivalent phantoms as patient surrogates to measure peripheral skin doses (Dskin) in lung cancer treatment through Volumetric Modulated Arc Therapy...